TNFRSF17 and Miyoshi myopathy: The combination of CRISPRi/CRISPRa functional genomics approaches have identified both antigen-dependent (HDAC7, SEC61A1) and antigen-independent pathways (GALE, GNE) that could control the response of MM cells to BCMA-targeted CAR-T-cells [123].